HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

6th Edition of World Congress on Infectious Diseases

June 24-26, 2024 | Paris, France

June 24 -26, 2024 | Paris, France

Infection 2024

Speaker at Infectious Diseases Conference - Daniel A. Lichtenstein
Keynote Presentation (In-Person)
Daniel A. Lichtenstein, Ambroise Pare Hospital, France

The BLUE-protocol is an ultrasound approach of lungs and veins, allowing with fine accuracies an immediate diagnosis of an acute respiratory failure among the six causes which regard 97% of patients seen in critical settings: hemodynamic pulmonary edema, pulmonary embolism, [....] » Read More

Speaker at Infectious Diseases Conferences - Saurabh Chattopadhyay
Keynote Presentation (In-Person)
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States

Will be Updated Soon...

Speaker at Infection Conference - De chu Christopher Tang
Oral Presentation (In-Person)
De chu Christopher Tang, VaxDome Inc., United States

Respiratory RNA viruses often mutate into new variants with subsets ravaging public health as escape mutants that render contemporary vaccines and antivirals ineffective from time to time. We have serendipitously developed an innovative approach to vaccine development against res [....] » Read More

Speaker at Infectious Diseases Conferences - Susannah Colt
Oral Presentation (In-Person)
Susannah Colt, Warren Alpert Medical School of Brown University, United States

Background: Children with intestinal schistosomiasis are at risk for undernutrition, anemia, linear growth stunting, and impaired cognitive development. Vitamin A deficiency impairs immune function against parasitic pathogens. In rodents, dietary-induced vitamin A deficiency caus [....] » Read More

Speaker at Infectious Diseases Conferences - Cristina Meehan
Oral Presentation (In-Person)
Cristina Meehan, National Institutes of Health, NIAID, United States

In 2023, malaria impacted 247 million individuals across 85 countries, resulting in 619,000 global deaths. The international focus to develop a higher efficacy malaria vaccine is a top priority, yet the complex parasite lifecycle poses a significant challenge to vaccine developme [....] » Read More

Speaker at Infectious Diseases Conference - Temitope Ibitoye
Oral Presentation (In-Person)
Temitope Ibitoye, North Carolina State University, United States

Throughout the COVID-19 pandemic, tracking both the prevalence of overall infection and the frequency of individual variants has been critical to understanding and responding to the pandemic. Having an accurate picture of infection rates and variant frequencies has been essential [....] » Read More

Speaker at Infection Conference - Daniela Tirotta
Oral Presentation (In-Person)
Daniela Tirotta, Morgagni - Pierantoni Hospital in Forlì, Italy

Introduction. Visceral leishmaniasis is an potentially fatal and neglected tropical disease, according to the World Health Organization’s : mortality is still very high ( 95% ) when untreated. This disease presents a broad spectrum of symptoms (oligosymptomatic infection, b [....] » Read More

Speaker at Infection Conferences - Marie Beaufrere
Oral Presentation (In-Person)
Marie Beaufrere, Paris-Saclay University, France

Introduction. Native joint and bone infections (NJBI) are frequently associated with infective endocarditis (IE). Normandy score, based on the patient's valvular assessment, the bacterial species and the hematogenous mechanism of NJBI was published to guide the prescription o [....] » Read More

Speaker at Infection Conference - Alexis Torres Rodriguez
Oral Presentation (In-Person)
Alexis Torres Rodriguez, Universidad Central del Caribe Internal Medicine Residency, Puerto Rico

Introduction: Pyogenic ventriculitis is characterized by ependymal lining inflammation of the cerebral ventricular system and presence of suppurative fluid in the ventricles. Risk factors include a compromised immunity such as human immunodeficiency virus, diabetes, and cancer. T [....] » Read More

Speaker at Infectious Diseases Conferences - Angelica Ludena
Oral Presentation (In-Person)
Angelica Ludena, Universidad Central del Caribe, Puerto Rico

Leptospirosis is a zoonotic disease produced by spirochetes of Leptospira, with an incidence ten times higher in tropical regions like Puerto Rico, in comparison to the rest of the world. The principal reservoir are rats, dogs, cats and farm animals with excreted infected urine, [....] » Read More

Speaker at Infectious Diseases Conference - Ahmed Esam Mahboub
Oral Presentation (In-Person)
Ahmed Esam Mahboub, Tawam Hospital, United Arab Emirates

Introduction: A previously healthy and a fully vaccinated 5-year-old pre-schooler-aged male who presented to the ER with an insidious onset of decreasing level of consciousness and headaches before developing Status Epilepticus, and requiring admission to the PICU; with a final [....] » Read More

Speaker at Infectious Diseases Conferences - Anne Morris
Oral Presentation (In-Person)
Anne Morris, North Bristol NHS Trust, United Kingdom

Background: Vaccination remains one of the most successful public health interventions in preventing severe disease and death. The roll-out of Covid-19 vaccination programmes has helped protect billions of people around the world against Covid-19. Most of these programmes have be [....] » Read More

Speaker at Infection Conferences - Mark Asare Owusu
Oral Presentation (In-Person)
Mark Asare Owusu, University of Cambridge, United Kingdom

The African meningitis belt, a region which stretches from Senegal to Ethiopia including Ghana, has experienced irregular but periodic epidemics of meningitis, primarily due to Neisseria meningitidis for over a hundred years. The introduction of MenAfriVac, a conjugate vaccine wh [....] » Read More

Speaker at Infectious Diseases Conferences - Zinaida Zagdyn
Oral Presentation (In-Person)
Zinaida Zagdyn, Semashko National Research Institute of Public Health in Moscow, Russian Federation

In Russia, with increase in life standard and following it improvement in the TB epidemic situation, socio-demographic, health care managing, climatic and environmental TB risk factors, such as population density, intensity of social contacts, availability of medical care, season [....] » Read More

Speaker at Infection Conference - Petersian M. Alcazaren
Oral Presentation (In-Person)
Petersian M. Alcazaren, West Visayas State University Medical Center, Philippines

Background: COVID-19 is a viral respiratory illness caused by SARS-CoV-2, confirmed with RTPCR testing. Considering the heterogeneity of clinical picture of COVID-19 disease, and the threats of its variants, the review of current clinical data and outcome of available management [....] » Read More

Speaker at Infectious Diseases Conferences - Golden Tamon-Gayo
Oral Presentation (In-Person)
Golden Tamon-Gayo, Baguio General Hospital and Medical Center, Philippines

Background: Cryptococcal meningitis (CM) is the most common central nervous system infection (CNSI) among patients with severe immunodeficiency syndrome secondary to human immune deficiency virus. Co-infection with other CNSI is relatively common especially with TB meningitis and [....] » Read More

Speaker at Infection Conference - Petersian M. Alcazaren
Oral Presentation (In-Person)
Petersian M. Alcazaren, West Visayas State University Medical Center, Philippines

Background As the world presently navigates the coronavirus disease 2019 (COVID-19) pandemic, there is a growing need to assess its impact in patients with underlying immunocompromised states, including autoimmune rheumatic diseases, such as systemic lupus erythematosus (SLE), an [....] » Read More

Speaker at Infectious Diseases Conferences - Helen Jane Polido
Oral Presentation (In-Person)
Helen Jane Polido, Baguio General Hospital and Medical Center, Philippines

Strongyloidiasis is caused by a soil-transmitted threadworm that is endemic worldwide and is more prevalent in humid climates. Taeniasis on the other hand, is an intestinal infection with tapeworms which is usually acquired by ingestion of parasite’s larval cysts in underco [....] » Read More

Speaker at Infectious Diseases Conference - Jaret Chessrence R. Consul
Oral Presentation (In-Person)
Jaret Chessrence R. Consul, University of Santo Tomas Hospital, Philippines

Background: Chronic pulmonary aspergillosis (CPA) is a rare lung disease caused by Aspergillus fungus, o en affec ng those with underlying lung condi ons. Pulmonary tuberculosis (PTB) is the leading cause of CPA worldwide, including an esmated 77,172 cases in the Philippines [....] » Read More

Speaker at Infectious Diseases Conference - Jaret Chessrence R. Consul
Oral Presentation (In-Person)
Jaret Chessrence R. Consul, University of Santo Tomas Hospital, Philippines

Background: Tuberculosis (TB) is a leading cause of adult deaths globally, with the Philippines ranking third, where almost one million people suffer from ac ve TB. Sadly, it claims almost 70 lives daily. EPTB is a rare form of TB, accoun ng for 14-15% of cases in 2005-2007, risi [....] » Read More

Speaker at Infectious Diseases Conferences - Nahla Omer Eltai
Oral Presentation (In-Person)
Nahla Omer Eltai, Qatar University, Qatar

Introduction: The spread of respiratory illnesses, such as COVID-19 pandemic, has posed a significant threat to millions of lives, leading to thousands of fatalities globally. This has sparked a concerning worldwide health crisis, underscoring the pivotal role of airborne transmi [....] » Read More

Speaker at Infection Conferences - Houssein Ayoub
Oral Presentation (In-Person)
Houssein Ayoub, Qatar University, Qatar

Background: The COVID-19 pandemic has highlighted the need to use infection testing databases to rapidly estimate effectiveness of prior infection in preventing reinfection (PEs) by novel SARS-CoV-2 variants. Methods: Mathematical modeling was used to demonstrate a theoretical [....] » Read More

Speaker at Infection Conferences - Yaun Shi
Oral Presentation (In-Person)
Yaun Shi, Children’s Hospital of Chongqing Medical University, China

Background: The initial clinical manifestations and abdominal imagines of neonates with necrotizing enterocolitis (NEC) and food protein-induced enterocolitis syndrome (FPIES) are sometimes similar, however, their prognosis and therapies are different. We aimed to evaluate the ut [....] » Read More

Speaker at Infectious Diseases Conferences - Xiaoyun Zhao
Oral Presentation (In-Person)
Xiaoyun Zhao, Tianjin University Chest Hospital, China

Purpose: In contemporary epochs, the prevalence of pertussis has been progressively on the rise, persisting as a formidable health concern. The manifestations following pertussis infection lean towards the atypical, making them easily disregarded or subject to misdiagnosis. Our a [....] » Read More

Speaker at Infectious Diseases Conference - Ahmed Hamdy Ghonaim
Oral Presentation (In-Person)
Ahmed Hamdy Ghonaim, Huazhong Agricultural University, China

Young animals and infants are vulnerable to severe gastroenteritis caused by Group A rotaviruses (RVAs). However, A lack of genomic data exists on the rotavirus A strains circulating in farm animals in China that may infect humans. We therefore screened the fecal samples collecte [....] » Read More

Speaker at Infectious Diseases Conference - Siwimol Phoomniyom
Oral Presentation (In-Person)
Siwimol Phoomniyom, The Office of Prevention and Disease Control 11th Region, Thailand

The trend of HIV infected people in Thailand has been declining since 2000. Owing to the Thailand's National Access to Antiretroviral Program for People who have AIDS (NAPHA) program promoting access to antiretroviral drugs, the use of antiretroviral drugs has been widespread [....] » Read More

Speaker at Infectious Diseases Conferences - Fatiha Hachani
Oral Presentation (In-Person)
Fatiha Hachani, Kasdi Merbah University, Algeria

Introduction: In December 2019, a new coronavirus identified in Wuhan, China was responsible for the rapid emergence of COVID-19, declared by the WHO a global pandemic in March 2020, responsible for a high rate of mortality and occurrence of acute and long-term complications. [....] » Read More

Speaker at Infectious Diseases Conferences - Banan Muneer Aiesh
Oral Presentation (In-Person)
Banan Muneer Aiesh, An-Najah National University Hospital, State of Palestine

Antimicrobial misuse is a worldwide issue, and antimicrobial resistance is considered one of the most challenging aspects of health care. It has been reported that as much as 30%–50% of antimicrobials prescribed in hospitals are unnecessary or inappropriate. Antib [....] » Read More

Speaker at Infection Conferences -  Raman Sharma
Oral Presentation (In-Person)
Raman Sharma, Post Graduate Institute of Medical Education And Research, India

Introduction: Varicella-zoster virus (VZV) infection in healthcare organisations, especially in ICUs, is of serious concern, primarily having admitted critical and immunocompromised patients. Methodology and Results: The report defines the transmission and infection control [....] » Read More

Speaker at Infectious Diseases Conferences - Gallusena Erickatulistiawan
Oral Presentation (In-Person)
Gallusena Erickatulistiawan, Brawijaya University – Saiful Anwar Hospital Malang, Indonesia

This study investigates the patterns of hospital-acquired infections, specifically analyzing bacterial isolates from a variety of clinical samples collected in the Intensive Cardiovascular Care Unit (CVCU) at Saiful Anwar Hospital in Malang, Indonesia, during the year 2022. This [....] » Read More

Speaker at Infection Conference - Ira Vori Nugroho
Oral Presentation (In-Person)
Ira Vori Nugroho, Universitas Brawijaya Malang, RS Dr. Saiful Anwar Jawa Timur, Indonesia

Introduction: Purulent pericarditis is defined as an infection in the pericardial space that produces macroscopically or microscopically purulent fluid.1 It was a rare but life-threatening condition.2 It may be primary or secondary to another infectious process. There are five pa [....] » Read More

Speaker at Infectious Diseases Conferences - Sagar Paudel
Oral Presentation (In-Person)
Sagar Paudel, Tribhuvan University Teaching Hospital, Nepal

Background Central nervous system (CNS) infections, such as meningitis and encephalitis, caused by various pathogens, can lead to serious morbidity and mortality, with diverse symptoms and outcomes. Survivors may face long-term neurological complications, making early treatment c [....] » Read More

Speaker at Infectious Diseases Conference - Caroline Ballet
Oral Presentation (In-Person)
Caroline Ballet, Fabentech, France

Successive sub-lineages of Omicron have spread since the occurrence of BA.1 in November 2021. Identified in July 2022, BQ.1 and BQ.1.1 expanded dramatically in Europe and North America. XBB and XBB.1 were first identified in India in mid-August 2022 and quickly spread to become p [....] » Read More

Speaker at Infectious Diseases Conference - Manuel Antonio Sierra Santos
Oral Presentation (In-Person)
Manuel Antonio Sierra Santos, Universidad Tecnologica Centroamericana, Honduras

Background/Introduction: COVID-19’s pandemic has had a catastrophic global impact, with nearly one billion reported infections and seven million deaths worldwide. By the middle 2020, several studies described the so-called long COVID syndrome as an emerging and prevalent sy [....] » Read More

Speaker at Infectious Diseases Conferences - Pedro Plans Rubio
Oral Presentation (In-Person)
Pedro Plans Rubio, Public Health Agency of Catalonia, Spain

The emergence of novel SARS-CoV-2 variants has raised concerns about the ability of COVID-19 vaccination programs to establish adequate herd immunity levels in the population. Adapted mRNA COVID-19 vaccines against BA.1 and BA.4-5 Omicron variants can provide a greater immunity a [....] » Read More

Speaker at Infectious Diseases Conferences - Claudia Ferreira
Oral Presentation (In-Person)
Claudia Ferreira, Biophytis Sorbonne, France

Background: SARS-CoV-2 infects human cells through interaction between its spike protein, and ACE2, a key element of the RAS. Thus  SARS-CoV-2 may induce  an imbalance of the RAS leading, among other symptoms, to severe pneumonia associated with COVID-19. We hypothesize [....] » Read More

Speaker at Infectious Diseases Conferences - Julissa Soto
Oral Presentation (In-Person)
Julissa Soto, Julissa Soto Latino Health Equity Consulting, United States

At the onset of the COVID-19 Pandemic, policymakers and public health officials often cited “vaccine hesitancy” as a key challenge to reaching vulnerable populations, including immigrants, Spanish-speaking communities, Latino communities, and others who have been marg [....] » Read More

Speaker at Infection Conference - Sukki Ho
Oral Presentation (In-Person)
Sukki Ho, The Hong Kong Polytechnic University, Hong Kong

Nasogastric tube (NG tube) feeding in residential care homes for the elderly (RCHEs) carries the risk of contamination at the NG tube hub, a crucial connection point in the enteral feeding process. This contamination can lead to the spread of harmful microorganisms, potentially r [....] » Read More

Speaker at Infection Conference - Abigail Kristine S. Juat
Oral Presentation (In-Person)
Abigail Kristine S. Juat, St. Luke’s Medical Center, Philippines

Kluyvera sp., an opportunistic Gram-negative bacillus found in clinical specimens such as sputum, urine, bile, peritoneal fluid, and blood, rarely causes significant infections. This case report manages a rare Kluyvera cryocrescens bacteremia in a female patient with chronic kidn [....] » Read More

Speaker at Infectious Diseases Conference - Quennie Bien Bien C. Yu
Oral Presentation (In-Person)
Quennie Bien Bien C. Yu, St. Luke’s Medical Center, Philippines

Kluyvera sp., an opportunistic Gram-negative bacillus found in clinical specimens such as sputum, urine, bile, peritoneal fluid, and blood, rarely causes significant infections. This case report manages a rare Kluyvera cryocrescens bacteremia in a female patient with chronic kidn [....] » Read More

Speaker at Infectious Diseases Conference - Abdallah Musa Abdallah
Oral Presentation (In-Person)
Abdallah Musa Abdallah, Qatar University, Qatar

Background: Coronavirus disease (COVID-19) is an infectious disease with a heterogeneous clinical presentation caused by the novel coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The distinctive features of COVID-19 infection encompass a clinical sp [....] » Read More

Speaker at Infection Conference - Karolina Viquez
Poster Presentation (In-Person)
Karolina Viquez, Indiana University, United States

Case presentation: 47 years old African American male presents with confusion. He arrived hemodynamically stable, oxygenation normal, encephalopathic. Laboratories showing acute kidney failure, creatinine 31md/dL, potassium 7.5mmol/L. Electrocardiogram with normal sinus rhythm wi [....] » Read More

Speaker at Infection Conferences - Melanie Rosado
Poster Presentation (In-Person)
Melanie Rosado, University of Utah, United States

A 4-day-old term infant with a low EOS risk score originally presented to the ED with six hours of lethargy and poor feeding. Initial work-up was demonstrated acute liver failure (PT/INR 18.5, ALT>90, AST>300), hypoglycemia, hyperferritinemia (ferritin >44,000), severe t [....] » Read More

Speaker at Infectious Diseases Conferences - Michele de Leon Jauregui
Poster Presentation (In-Person)
Michele de Leon Jauregui, University of Utah, United States

A 4-day-old term infant with a low EOS risk score originally presented to the ED with six hours of lethargy and poor feeding. Initial work-up was demonstrated acute liver failure (PT/INR 18.5, ALT>90, AST>300), hypoglycemia, hyperferritinemia (ferritin >44,000), severe t [....] » Read More

Speaker at Infectious Diseases Conference - Elucir Gir
Poster Presentation (In-Person)
Elucir Gir, University of Sao Paulo, Ribeirao Preto College of Nursing, Brazil

Introduction: Facing the COVID-19 pandemic caused damage to the physical health of nurses, especially those who worked on the so-called front line, as they were exposed to constant risks of contamination, exhaustive workload and difficulties in the availability of inputs, such as [....] » Read More

Speaker at Infectious Diseases Conference - Elucir Gir
Poster Presentation (In-Person)
Elucir Gir, University of Sao Paulo, Ribeirao Preto College of Nursing, Brazil

Introduction: Long COVID comprises a complex, multidimensional, progressive and impactful syndrome characterized by the persistence of residual symptoms after the initial COVID-19 infection, without an alternative diagnosis or associated condition. Objective: To identify the p [....] » Read More

Speaker at Infectious Diseases Conferences - Zucatelli
Poster Presentation (In-Person)
Zucatelli, Instituto Butantan, Brazil

Introduction: The coronavirus has become known because of the COVID 9 pandemic. Coronaviruses cause epidemics not only in humans, but also in animals of commercial interest such as birds (Infectious bronchitis virus-IBV). This virus has a replication mechanism similar to the huma [....] » Read More

Speaker at Infectious Diseases Conference - Simona Yoffe Deri
Poster Presentation (In-Person)
Simona Yoffe Deri, Sheba Hospital, Israel

Influenza B-associated rhabdomyolysis is relatively rare. Herein, we describe a retrospective case-series of five children hospitalized in a single institution for rhabdomyolysis from PCR-confirmed Influenza B. Viral sequencing revealed a novel deletion of one amino acid in the v [....] » Read More

Speaker at Infectious Diseases Conference - Simona Yoffe Deri
Poster Presentation (In-Person)
Simona Yoffe Deri, Sheba Hospital, Israel

Background: Necrotizing Enterocolitis (NEC), one of the most severe emergencies in neonates, is a multifactorial disease with diverse risk factors. Objectives: To compare between the clinical and laboratory characteristics of premature infants diagnosed with early-onset NEC (E [....] » Read More

Speaker at Infection Conference - Liu Yen Hung
Poster Presentation (In-Person)
Liu Yen Hung, Cardinal Tien Hospital, Taiwan

Introduction: SARS-CoV-2 has spread worldwide and dramatically and devastatingly impacted our society. Quarantine has been taken to slow down its spread. Due to some adverse impacts on individuals and communities caused by quarantine, other interventions, such as vaccination and [....] » Read More

Speaker at Infection Conference - Prachi Urade
Poster Presentation (In-Person)
Prachi Urade, National Centre for Cell Science, India

Tuberculosis (TB), caused by Mycobacterium tuberculosis, is one of the deadliest diseases worldwide. The major challenge to the existing TB treatment is the emergence of Multidrug Resistant (MDR) M. tuberculosis which limits the success rate of treatment and therefore generating [....] » Read More

Speaker at Infectious Diseases Conferences - Aishwarya Vyas
Poster Presentation (In-Person)
Aishwarya Vyas, SMS Medical College, India

Purpose: To evaluate the spectrum of coagulopathy in acute sepsis and to correlate it with sequential physiological scores (SOFA & APACHE II) and compare the findings among survivors and non-survivors.  DESIGN: Prospective cohort   Methods: It is a prospective c [....] » Read More

Speaker at Infection Conferences - Lilishia Gounder
Poster Presentation (In-Person)
Lilishia Gounder, University of KwaZulu-Natal, South Africa

Background: HIV drug resistance (HIVDR) remains a major threat to achieving sustainable viral suppression in patients on antiretroviral therapy (ART). In South Africa, since its rollout in December 2019, dolutegravir (DTG) has been the preferred ART backbone. Methods: We curat [....] » Read More

Speaker at Infection Conference - Jiahui Zhu
Poster Presentation (In-Person)
Jiahui Zhu, University of Helsinki, Finland

Background: Data on the molecular epidemiological characteristics and transmission of drug-resistant Mycobacterium tuberculosis (MTB) in low-incidence settings with immigration from high-incidence settings is limited. Method: We included 115 drug-resistant (DR) MTB isolates wi [....] » Read More

Speaker at Infection Conference - Jiahui Zhu
Poster Presentation (In-Person)
Jiahui Zhu, University of Helsinki, Finland

Background: The omicron variant of SARS-CoV-2 has been proven as a diversified variant with lower risk for public health than the previous variants. Public health policy has been adjusted toward endemic COVID-19. Understanding the molecular evolution and epidemiological character [....] » Read More

Speaker at Infection Conferences - Kristine Mae D. Barredo
Poster Presentation (In-Person)
Kristine Mae D. Barredo, Zamboanga City Medical Center, Philippines

Introduction: Defining the epidemiological and clinical features of COVID in pediatric patients can aid in the control of spread and improve the curative rate. Objectives: This study determined the epidemiological and clinical characteristics of COVID confirmed children admitt [....] » Read More

Speaker at Infectious Diseases Conference - Ashley Zhou
Poster Presentation (In-Person)
Ashley Zhou, Mayo Clinic, United States

Skin and soft tissue infections (SSTI) represent an uncommon source of infection (<10%) in patients with persistent or recurring fever and neutropenia.1-3 Worldwide, the prevalence of immunocompromised hosts is increasing even as the incidence of gram-negative and of multidrug [....] » Read More

Speaker at Infectious Diseases Conferences - Jared Alphonse S. Cordero
Poster Presentation (In-Person)
Jared Alphonse S. Cordero, St. Luke's Medical Center, Philippines

Background of the study: Chronic aspiration is common in patients with uncontrolled gastrosophageal reflux disease (GERD). Aspiration can cause recurrent pneumonia, chemical pneumonitis, and in rare cases, organizing pneumonia. Head and neck tumors needing high dose radiatio [....] » Read More

Speaker at Infection Conferences - Oscar Inacio
Oral Presentation (In-Person)
Oscar Inacio, Universidade Federal de Campina Grande, Brazil

This meta-analysis aims to verify the efficacy of conventional endotracheal tubes (PVC) and polymer-coated tubes in combating ventilator-associated pneumonia (VAP) in patients ventilated for more than 48 hours. Thus, after observing the statistical graphs, we found that the coate [....] » Read More

Speaker at Infection Conference - Deepti KC
Oral Presentation (In-Person)
Deepti KC, Glasgow Caledonian University, United Kingdom

Introduction: Effective infection prevention and control (IPC) programs can significantly reduce healthcare-associated infections by up to 70%. However, a global disparity exists in meeting minimum IPC requirements, with high-income countries over eight times more likely to have [....] » Read More

Speaker at Infection Conferences - Hideliz Marie G Pascua
Oral Presentation (In-Person)
Hideliz Marie G Pascua, Baguio General Hospital and Medical Center, Philippines

Candida duobushaemulonii is a yeast that belongs to the Candida haemulonii species complex. Similar to Candida auris which is an emerging global health threat, C. duobushaemulonii is a major concern in the healthcare system as it is often multidrug resistant. Prese [....] » Read More

Speaker at Infection Conferences - Stephanie Obienda Palacios
Oral Presentation (In-Person)
Stephanie Obienda Palacios, West Visayas State University Medical Center, Philippines

Introduction: Hospital-acquired pneumonia (HAP) increases morbidity, mortality, and healthcare costs, thus additional epidemiologic studies are necessary to better understand the problem’s scope and develop interventions. Considering that HAP is an exogenous infection with [....] » Read More

Speaker at Infection Conference - Priya Godara
Oral Presentation (In-Person)
Priya Godara, Central University of Rajasthan, India

The continuous drug resistance in parasites against the majority of the front-line antimalarials has resulted in countless deaths in malaria-endemic countries, with an estimated 619,000 deaths in 2021. Notably, the recent malaria outbreak during 2020–21 at Attapeu (Laos) ca [....] » Read More

Speaker at Infectious Diseases Conference - Nitosh Kumar Brahma
Oral Presentation (In-Person)
Nitosh Kumar Brahma, Indian Institute of Chemical Engineers, India

Since the discovery of Double Helix by Watson and Crick in 1953 and its advancement in medicine, environment, unit operational bioreactor design, used in vaccine development and food. The application of nanotechnology and biotechnology are also being potentially used in processin [....] » Read More

Speaker at Infectious Diseases Conferences - Ashish Jmc Sinha
Oral Presentation (In-Person)
Ashish Jmc Sinha, Pt Jnm Medical College Raipur, India

Introduction: Patients with undiagnosed pulmonary TB act as reservoirs for transmission and will result in 10-15 secondary infections in 1-5 Yrs. Health seeking behavior plays important role in early diagnosis and prompt treatment in TB care. Identification of factors influencing [....] » Read More

Speaker at Infectious Diseases Conferences - Rosshini Kummararaj
Oral Presentation (In-Person)
Rosshini Kummararaj, Yenepoya Medical College, India

Introduction: A parasite may look docile and harmless but it can create havoc in human eyes. Early detection and timely treatment can prevent blindness. We report three cases of parasites in the eye with varying presentations. Case 1: A 76-year-old gentleman, a pet lover and a [....] » Read More

Speaker at Infection Conferences - Anil Budania
Oral Presentation (In-Person)
Anil Budania, All India Institute of Medical Sciences, India

Introduction: Urethritis and cervicitis, in the majority of cases, are caused by sexually transmitted agents. They presents as discharge, pain, burning sensation but sometimes the patient may remain asymptomatic. Neisseria gonorrhoeae (Gono-coccal) and chlamydia trachomatis (Non- [....] » Read More

Speaker at Infectious Diseases Conference - Siraaj Adams
Oral Presentation (In-Person)
Siraaj Adams, UWC School of Pharmacy, South Africa

This academic abstract offers an in-depth exploration of the journey toward implementing the Pharmacy Initiated Management of Antiretroviral Therapy (PIMART) initiative while also considering the potential benefits of integrating digital health e-prescription processes via teleme [....] » Read More

Speaker at Infection Conferences - Brian Sri Prahastuti
Oral Presentation (In-Person)
Brian Sri Prahastuti, M.H Thamrin University, Indonesia

Background: Women living with HIV face stigma and discrimination in obtaining health services. Not only those related to HIV services (screening, testing, ARV treatment and viral load monitoring) but also maternal ANC (antenatal care), delivery and PNC (postnatal) services, as we [....] » Read More

Speaker at  - Zubair Ali Khowaja
Oral Presentation (In-Person)
Zubair Ali Khowaja, Dow University of Health Sciences, Pakistan

Background: Tuberculoma and cerebral infarctions are serious complications of central nervous system (CNS) tuberculosis. However, there are no studies comparing prognostic value of tuberculoma and infarcts alone and in patients diagnosed with CNS tuberculosis. Objective: The o [....] » Read More

Speaker at  - Leresche Even Doneilly Oyaba Yinda
Oral Presentation (In-Person)
Leresche Even Doneilly Oyaba Yinda, Interdisciplinary Medical Research Center of Franceville, Gabon

Background: Terrestrial mammals in protected areas have been identified as a potential source of antimicrobial-resistant bacteria. Studies on antimicrobial resistance in gorillas have already been conducted. Thus, this study aimed to describe the phylogroups, pathotypes and preva [....] » Read More

Speaker at Infectious Diseases Conferences - Toukap Edouard Milaine Orline
Oral Presentation (In-Person)
Toukap Edouard Milaine Orline, Institute of Medical Research and Medicinal Plants Studies, Cameroon

Cultural beliefs and educational factors strongly influence intravaginal practices of women in Sub Saharan Africa. These behaviors appear common in different population across Africa. Previous research has suggested that vaginal douching modifies vaginal flora and was associated [....] » Read More

Speaker at  - Justine Umutesi
Oral Presentation (In-Person)
Justine Umutesi, Rwanda Biomedical Centre, Rwanda

The consequences of hepatitis C virus infection (HCV), a curable disease, are a major problem for the survival of the world's population, particularly in Africa. Over the decades, hepatitis has been viewed differently in various African countries, but the common denominator w [....] » Read More

Speaker at  - Claude Mumba
Oral Presentation (In-Person)
Claude Mumba, Eastern Provincial Health Office, Zambia

Background: HIV prevalence amongst adults aged 15 and above in Zambia was 11.0% (ZAMPHIA 2022). Prevalence of viral load suppression amongst adults aged 15 and above living with HIV in Zambia was 86.2% at Sinda Zonal Health Centre by 2022. However, because of this burden, combine [....] » Read More

Speaker at  - Alan Kachuka
Oral Presentation (In-Person)
Alan Kachuka, Ministry of Health, Sinda District Health Office, Sinda, Eastern Province, Zambia

Background: COVID-19 has shown to put people living with HIV (PLHIV) at a higher risk of catastrophic consequences and mortality. Research suggests that PLHIV who contract Corona virus (SARS-CoV-2) are more likely to require hospitalization and have poor clinical outcomes th [....] » Read More

Speaker at Infection Conference - Amonchy Elvis Kotchi
Oral Presentation (In-Person)
Amonchy Elvis Kotchi, The Ministry of Health and Public Hygiene and Universal Health Coverage, Cote d'Ivoire

Pneumonia, the second leading cause of infant mortality in Côte d'Ivoire, remains unknown to the great one. Among the leading causes of environment-related child deaths, 570,000 children under 5 die from respiratory infections caused by indoor and outdoor air pollution [....] » Read More

Speaker at Infection Conferences - Dana Naeem Ashoor
Oral Presentation (In-Person)
Dana Naeem Ashoor, Arabian Gulf University, Bahrain

The current globally dominant SARS-CoV-2 variants are showing immune escape caused by genetic variations of SARS-CoV-2 S protein epitopes, affecting the efficiency of COVID-19 antibody-based therapy. Agencies responsible for drug evaluation and regulation such as the FDA and EMA [....] » Read More

Speaker at Infectious Diseases Conference - M. Dahmani Fath Allah
Oral Presentation (In-Person)
M. Dahmani Fath Allah, Arabian Gulf University, Bahrain

The high genetic variability of the new coronavirus SARS-CoV-2 that caused the ongoing severe acute respiratory syndrome related coronavirus 2 disease (COVID19) pandemic, is urging the development of precision vaccines. We herein, present the development of vaccine subunits that [....] » Read More

Speaker at Infectious Diseases Conferences - Nadine Bacalangco Suerte
Oral Presentation (In-Person)
Nadine Bacalangco Suerte, West Visayas State University Medical Center, Philippines

Background: Vaccination across countries against COVID-19 have shown to be effective against infection and mortality in different settings. However, recent data describe breakthrough COVID-19 infection among vaccinated individuals. Risk factors and clinical characteristics have b [....] » Read More

Speaker at Infectious Diseases Conference - Anupma Harshal W
Oral Presentation (In-Person)
Anupma Harshal W, Consultant-Kotak Education Foundation & Ashoka University, India

Background: Antimicrobial resistance (AMR) is a global public health concern that threatens the effectiveness of antibiotics and other antimicrobial drugs. As a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective and infections become diffi [....] » Read More

Speaker at Infection Conferences - Yousra Abdelmoumen
Oral Presentation (In-Person)
Yousra Abdelmoumen, faculty of pharmacy of Casablanca, Morocco

Parvovirus B19, a small, single-stranded DNA virus belonging to the Parvoviridae family, has long been recognized as a significant human pathogen. Despite its diminutive size, Parvovirus B19 infection manifests in a spectrum of clinical presentations, ranging from benign childhoo [....] » Read More

Speaker at Infectious Diseases Conferences - Francisco Borges Costa
Oral Presentation (In-Person)
Francisco Borges Costa, University of Maranhoo, Brazil

Rabies is an acute viral disease that affects mammals, caused by an RNA virus belonging to the family Rhabdoviridae and the genus Lyssavirus. The disease is transmitted through bites or scratches from an infected animal. Rabies was one of the first infectious diseases to be scien [....] » Read More

Speaker at Infection Conferences - Wenjie Wu
Oral Presentation (In-Person)
Wenjie Wu, Banan Hospital affiliated to Chongqing Medical University, China

Objective: The objective of this study was to assess clinical isolates of Mycobacterium tuberculosis using a microfluidic chip, simultaneously detecting eight drug-resistant genes associated with first- and second-line anti-tuberculosis drugs. These findings were compared with ph [....] » Read More

Speaker at Infection Conference - Renata Karina Reis
Poster Presentation (In-Person)
Renata Karina Reis, University of Sao Paulo, Ribeirao Preto College of Nursing, Brazil

Introduction: The presence of an untreated STI significantly increases the chance of acquiring HIV. In Brazil, CT/NG testing among PrEP users is insufficient and syndromic treatment is a priority in clinical practice. Multi-site testing for CT/NG improves screening of asymptomati [....] » Read More

Speaker at Infection Conferences - Amille Joy
Poster Presentation (In-Person)
Amille Joy, Eastern Visayas Medical Center, Philippines

Introduction: Tetanus is an acute disease caused by a powerful neurotoxin produced by the bacterium Clostridium tetani manifested by skeletal muscle spasm and autonomic nervous system disturbance. It is and is completely preventable by vaccination. In 2017, that the Philippine go [....] » Read More

Speaker at Infection Conferences - Silvia Giono Cerezo
Poster Presentation (In-Person)
Silvia Giono Cerezo, Instituto Politecnico Nacional, Mexico

 Acinetobacter baumannii is an opportunistic pathogen responsible for healthcare-associated infections (HAIs) and outbreaks. Antimicrobial resistance mechanisms and virulence factors allow it to survive and spread in the hospital environment. However, the molecular mechanism [....] » Read More

Speaker at Infection Conference - Tarek Kamal Motawi
Poster Presentation (In-Person)
Tarek Kamal Motawi, Cairo University, Egypt

Aim: Diabetic nephropathy (DN) is considered as one of the diabetic complications affectingup to 40% of patients with type 1 or type 2 diabetes. In clinical practice, the frequentlyused markers of renal disease and progression are serum creatinine, estimated glomerular filtration [....] » Read More

Speaker at Infectious Diseases Conference - Sana Tanweer
Poster Presentation (In-Person)
Sana Tanweer, Jamia Hamdard University, India

 Tuberculosis (TB) is a deadly disease that is difficult to treat. Existing drugs are not always effective, and new drugs are needed. Drug repurposing has become a popular approach for drug discovery due to the advancements in high throughput computational screening methods. [....] » Read More

Speaker at Infection Conferences - Priya Priydarshni
Poster Presentation (In-Person)
Priya Priydarshni, ICMR-RMRIMS, India

Visceral leishmaniasis caused by Leishmania are pathogenic protozoans that primarily attack mammalian macrophages, dwells within it as intracellular parasite requiring iron (Fe) from host.  Host iron acquisition by Leishmania spp. is crucial for DNA replication, mitochondria [....] » Read More

Speaker at Infection Conferences - Mahendra Kumar
Poster Presentation (In-Person)
Mahendra Kumar, National Centre for Cell Science, India

Mycobacterium tuberculosis (Mtb) is the oldest pathogen of the mankind, responsible for the Tuberculosis (TB) disease in humans. TB infection is the leading cause of morbidity and mortality accounted by a single pathogen. Despite all the efforts to develop a new vaccination strat [....] » Read More

Speaker at Infectious Diseases Conferences - Preeti Chaudhary
Poster Presentation (In-Person)
Preeti Chaudhary, Indian Council of Medical Research-NIMR, India

Malaria remains a global health issue affecting half of the world's population. The current treatment regimen which includes artemisinin and other combination therapies is being threatened with the rapid emergence of resistance. P. falciparum under drug pr essure has revealed [....] » Read More

Speaker at Infectious Diseases Conferences - Tripti Pal Raman
Poster Presentation (In-Person)
Tripti Pal Raman, World Health Organization, Nepal

Background: In Nepal significant increase of zero dose children from1% to 4% have alerted all the stakeholders associated with child immunization1. In addition to this increasing outbreak of vaccine preventable diseases in the areas with low vaccination dose are showing importanc [....] » Read More

Speaker at Infection Conferences - Racha Boubekeur
Poster Presentation (In-Person)
Racha Boubekeur, Parsitology-Mycology Laboratory at the Army Central Hospital, Algeria

In hospitals, yeast of the genus Candida species albicans has played an important role in infections for over two decades. It is the fourth most common cause of septicemia in the USA and seventh in Europe. In terms of seriousness, it is associated with a high mortality rate, espe [....] » Read More

Speaker at Infection Conferences - Racha Boubekeur
Poster Presentation (In-Person)
Racha Boubekeur, Parsitology-Mycology Laboratory at the Army Central Hospital, Algeria

The incidence of mycoses caused by Candida spp. has increased steadily over the past two decades, Candida albicans remains the most commonly isolated microscopic fungus. The objective of our study was to identify the profile of a few strains of Candida albicans isolated from diff [....] » Read More

Speaker at Infection Conferences - Khalid
Poster Presentation (In-Person)
Khalid, Sultan Qaboos University Hospital, Oman

Objectives and rationale: This study aims to investigate the prevalence, demographics, and risks of co-infections among hospitalized patients at Sultan Qaboos University Hospital (SQUH); a tertiary-care hospital in Muscat, Oman. Aim: This study aims to identify the most common [....] » Read More

Speaker at Infection Conference - Andrew Kimera
Poster Presentation (In-Person)
Andrew Kimera, Makerere University, Uganda

Background: Hepatitis B virus (HBV) is associated with several acute and long-term complications and vaccination is the cornerstone of prevention.  A recent outbreak in Gulu, Uganda, one of the districts covered by a mass vaccination campaign, suggests low uptake of HBV vacc [....] » Read More

Speaker at Infection Conference - Andrew Kimera
Poster Presentation (In-Person)
Andrew Kimera, Makerere University, Uganda

Background: Hepatitis B virus vaccination plays a crucial role in preventing Hepatitis B infection, particularly in high-risk groups such as children under-five, who have a 60-90% higher chance of seroconversion. As per the World Health Organization (WHO), about 5–10% of in [....] » Read More

Speaker at Infection Conference - Patrone Rebecca Risenga
Poster Presentation (In-Person)
Patrone Rebecca Risenga, University of South Africa, South Africa

Human Immunodeficiency Virus creates disruption in the lives of individuals, families, organisations, and communities at large. The introduction of the antiretroviral treatment brought hope but also brought challenges, especially around the issue of adherence which is important f [....] » Read More

Speaker at Infection Conference - Micah Fiel C. Baliclic
Poster Presentation (In-Person)
Micah Fiel C. Baliclic, St.Luke’s Medical Center-Global City, Philippines

Salmonellosis typically manifests as gastrointestinal symptoms, but rarely may also present as focal infection via the hematogenous spread of the bacteria. The incidence of neck abscess caused by Salmonella is low and there have been few cases reported among patients with uncontr [....] » Read More

Speaker at Infection Conferences - Fatima Ahmed
Poster Presentation (In-Person)
Fatima Ahmed, London School of Hygiene and Tropical Medicine, United Kingdom

Introduction: Although Aedes aegypti is routinely cited as the principal mosquito vector of dengue virus, there is limited evidence base around its contribution relative to A. albopictus. Methods: We performed a systematic review and meta-analysis to compare the dengue prevale [....] » Read More

Speaker at Infection Conferences - Vecky Cyril S. Verzosa
Poster Presentation (In-Person)
Vecky Cyril S. Verzosa, Divine Word Hospital, Philippines

Background: Several vaccines have been approved for use against COVID-19 infection. Public health measures promoting compliance to COVID-19 vaccination require understanding of knowledge, attitudes and practices (KAP). Objectives: This study explored the KAP towards COVID-19 v [....] » Read More

Speaker at Infectious Diseases Conferences - Faith Hope Lesigues
Poster Presentation (In-Person)
Faith Hope Lesigues, Divine Word Hospital, Philippines

Background. Carbapenem is a class of antibiotics with wide spectrum of activity used as drug of last resort reserved for suspected multidrug-resistant organisms. The increasing incidence of carbapenem-resistant organisms remains a growing concern worldwide. Although a national su [....] » Read More

Speaker at Infection Conference - Rakesh Kumar Deepak
Poster Presentation (In-Person)
Rakesh Kumar Deepak, All India Institute of Medical Sciences, India

The coronavirus pandemic is still a major public health problem worldwide. It was started in Wuhan (a city in China), and the individuals started reporting the clinical manifestations were fever (moderate to high), dry cough, body aches, diarrhea, and headache. Usually, disease m [....] » Read More

Speaker at Infectious Diseases Conference - Lata Kumari
Poster Presentation (In-Person)
Lata Kumari, All India Institute of Medical Sciences, India

Introduction: Gallbladder cancer is the 5th most common gastrointestinal cancer. Early diagnosis is not generally possible. The outlook is poor for recovery if the cancer is found after symptoms have started to occur, with a 5-year survival rate of close to 3%. The prognosis stil [....] » Read More

Speaker at Infectious Diseases Conferences - Maria De Fatima Ferreira Da Cruz
Poster Presentation (In-Person)
Maria De Fatima Ferreira Da Cruz, Fundacao Oswaldo Cruz, Brazil

Malaria is a public health problem and the cases diagnosed in the capital of Roraima have the potential to characterize the burden of the disease in the state. This study aimed to describe the epidemiological, clinical and laboratory aspects of malaria cases diagnosed in Boa Vist [....] » Read More

Speaker at Infection Conferences - Reza Nassiri
Keynote Presentation (Virtual)
Reza Nassiri, Michigan State University, United States

Antibiotic resistance (AR) is both clinical and global public health concerns. In numerous countries, physicians have very few other options available to treat MDR and XDR infections. The World Health Organization (WHO) acknowledges AR is one of the top global public he [....] » Read More

Speaker at Infectious Diseases Conferences - Krzysztof Skowron
Keynote Presentation (Virtual)
Krzysztof Skowron, Nicolaus Copernicus University in Torun, Poland

The increase in the transfer of pathogenic microorganisms between humans, livestock, wildlife and their environment observed in recent years, as well as the irrational use of antibiotics, makes it increasingly difficult to combat the growing multidrug resistance of bacteria such [....] » Read More

Speaker at Infection Conferences - Seki Masafumi
Keynote Presentation (Virtual)
Seki Masafumi, Saitama Medical University International Medical Center, Japan

Background: The mortality of SARS-CoV-2 infection in non-vaccinated patients is still thought to be high despite the appearance of the omicron subvariant. A total of 36 adult, non-vaccinated patients who were hospitalized with SARS-CoV-2 infection during the omicron variant surge [....] » Read More

Speaker at Infection Conferences - Aung Sitt Naing
Oral Presentation (Virtual)
Aung Sitt Naing, Eastern Virginia Medical School, United States

Introduction: Schistosomiasis is a parasitic infection endemic to Asia, Africa, and South America, and can be an unusual cause of pelvic pain in women. Due to similar symptoms with endometriosis, the diagnosis is often missed in regions of the world where Schistosomiasis is uncom [....] » Read More

Speaker at Infection Conferences - Casey Hamlet
Oral Presentation (Virtual)
Casey Hamlet, Rutgers New Jersey Medical School, United States

Background: As of 2020, 71.5% of tuberculosis (TB) cases in the United States occur in foreign-born patients.1 Gaps in healthcare, congregate living conditions, are just some of the challenges that immigrants and refugees from high incidence countries face that make them especi [....] » Read More

Speaker at Infection Conferences - Aung Sitt Naing
Oral Presentation (Virtual)
Aung Sitt Naing, Eastern Virginia Medical School, United States

Introduction: Mycobacterium shimoidei is a rare, slow-growing nontuberculous mycobacterium, first isolated in Japan in 1968. Only one case was reported in the United States, out of a total of fifteen cases reported worldwide. Due to its rarity and the current understanding o [....] » Read More

Speaker at Infection Conference - Ahmad Subhi
Oral Presentation (Virtual)
Ahmad Subhi, Al Qassimi Hospital, United Arab Emirates

In 2016, according to the United States Centers for Disease Control and Prevention (CDC), and Public Health England, Candida auris, has been labeled as an emerging multidrug-resistant (MDR) yeast. Despite causing significant mortality, there are still no available Minimum inhibit [....] » Read More

Speaker at Infectious Diseases Conference - Nashwa Elsayed Elkasaby
Oral Presentation (Virtual)
Nashwa Elsayed Elkasaby, Medical Microbiology and immunology Department, Faculty of medicine, Mansoura University, Egypt

Background and aim: Human parechovirus (HPeV) has emerged as a pathogen associated with acute gastroenteri? tis (AGE). Aim: To detect the presence of HPeV in the stool samples from Egyptian children with AGE seeking care and the pos? sibility of its co?infection with other ent [....] » Read More

Speaker at Infectious Diseases Conference - Anastasiia Panova
Oral Presentation (Virtual)
Anastasiia Panova, Bauman Moscow State Technical University, Russian Federation

COVID-19 type virus infection in a group of individuals results from the uptake by the lungs of these individuals of virions from the local atmosphere created by infected members of the group. The concentration of virions is determined by the social activity of group members and [....] » Read More

Speaker at Infectious Diseases Conference - Nikita Thomas
Oral Presentation (Virtual)
Nikita Thomas, Aster Medcity, India

We present a case of West Nile Virus Encephalitis .West Nile fever is an infection by the West Nile virus, which is typically spread by mosquitoes. WNV is one of the Japanese encephalitis antigenic serocomplex of viruses.In about 80% of infections people have few or no symptoms. [....] » Read More

Speaker at Infectious Diseases Conferences - Prajwal Krishna K
Oral Presentation (Virtual)
Prajwal Krishna K, Madras Medical College, India

Introduction: Disseminated tuberculosis is a severe form of the disease involving two or more non-contiguous body sites or blood or bone marrow concurrently.The diagnosis and management often pose a challenge due to varied clinical presentations. Case Report: We report a case [....] » Read More

Speaker at Infection Conference - Aji Antony
Oral Presentation (Virtual)
Aji Antony, Government Medical College Kozhikode, India

Background: Histoplasmosis is an endemic mycosis that is usually asymptoma c but occasionally results in severe illness. While it is endemic in some regions of the world, including America, Africa, and parts of Asia, it is considered rare in India. Most pa ents who develop dissem [....] » Read More

Speaker at Infection Conference - Aji Antony
Oral Presentation (Virtual)
Aji Antony, Government Medical College Kozhikode, India

Introduction: Stroke in a case of HIV, occurs by various mechanisms. The mechanisms include vasculi s secondary to opportunis c infec ons, HIV associated vasculopathy, cardioembolic stroke and HIV associated coagulopathy. Of these, the HIV associated vasculopathy is a diagnosis o [....] » Read More

Speaker at Infection Conferences - Ndifontiayong Adamu Ndongho
Oral Presentation (Virtual)
Ndifontiayong Adamu Ndongho, Dschang University, Cameroon

Hepatitis B (HBV) and C (HCV) are two among other forms of infections for which co-infection in HIV has been associated with alteration of the immune response, increased risk of progression to liver diseases and increased risk of hepatotoxicity associated to antiretroviral therap [....] » Read More

Speaker at Infectious Diseases Conference - Helmi Ernandes
Oral Presentation (Virtual)
Helmi Ernandes, Mohamed Kassab Institute of Orthopedics, Tunisia

Background: Periprosthetic joint infection (PJI) is the most common and feared arthroplasty complication. Ralstonia pickettii is an opportunistic Gram-negative bacterium, causing nosocomial infections in immunocompromised patients. It is an environmental bacterium that has been a [....] » Read More

Speaker at Infectious Diseases Conference - Helmi Ernandes
Oral Presentation (Virtual)
Helmi Ernandes, Mohamed Kassab Institute of Orthopedics, Tunisia

Background: The rate of septic arthritis after arthroscopy ranges from 0.15% to 1%. Staphylococci are the leading causative organisms after knee arthroscopy whereas Cutibacterium acnes is often the causative organism after shoulder arthroscopy. Gram-negative bacillary infections [....] » Read More

Speaker at Infection Conference - Dian Wulandaru Sukmaning Pertiwi
Oral Presentation (Virtual)
Dian Wulandaru Sukmaning Pertiwi, University of Indonesia, Indonesia

Objective: Survival rate and quality of life of children with chronic hepatobiliary disease has improved since the development of liver transplantation. Incidence of bacterial infection is 36– 79% at 6 months post-transplantation and mortality of 3.0–10.6% at 3 months [....] » Read More

Speaker at Infectious Diseases Conference - Rima Al balushi
Oral Presentation (Virtual)
Rima Al balushi, University of Nebraska Medical Center, United States

Introduction: The World Health Organization (WHO) and the Global Health Security Index (GHSI) reported a lack of biosecurity and biosafety capacity and practice across the Middle East and North Africa (MENA) region. Private human and animal diagnostic laboratories in Egypt play a [....] » Read More

Speaker at Infectious Diseases Conferences - Arjun Chadha
Oral Presentation (Virtual)
Arjun Chadha, Michigan State University, United States

Syphilis is a venereal or vertically transmitted infectious disease caused by Treponema pallidum, a corkscrew shaped, motile spirochete. It generally progresses via stages and, if left untreated, can result in devastating cardiovascular and neurological sequelae. Ocular syphil [....] » Read More

Speaker at Infectious Diseases Conferences - Nicole Abdullah
Oral Presentation (Virtual)
Nicole Abdullah, Faculdades Pequeno Príncipe, Brazil

Introduction: Severe acute respiratory syndrome coronavirus-2 virus (SARS-COV-2) was officially identified on January 2020 following investigations of pneumonia cases of unknown origin. Clinical presentation presents variations in symptom duration, severity, and complications. Am [....] » Read More

Speaker at Infectious Diseases Conference - Tran Lam Tu Quyen
Oral Presentation (Virtual)
Tran Lam Tu Quyen, China Medical University, Taiwan

The Acinetobacter baumannii group (AB-group), encompassing A. baumannii, A. pittii, A. nosocomialis, along with recent additions A. seifertii and A. dijkshoorniae, have emerged as prominent nosocomial pathogens with a global presence. Infections with antibiotic-resistant Acinetob [....] » Read More

Speaker at Infectious Diseases Conference - Nikki Kasal
Poster Presentation (Virtual)
Nikki Kasal, University of Chicago Pritzker School of Medicine, United States

Background: Awareness and uptake of HIV pre-exposure prophylaxis (PrEP) remains low among Black/African American cisgender women at risk for HIV acquisition. Primary care appointments present a valuable opportunity for introducing PrEP to clients; however, primary care providers [....] » Read More

Speaker at Infectious Diseases Conferences - Ashin Mehta
Poster Presentation (Virtual)
Ashin Mehta, Medical College of Wisconsin, United States

A 56-year-old male with end-stage renal disease undergoing home peritoneal dialysis presented with abdominal pain, nausea, and altered mental status. White blood cell count was 12.3 10e3/uL, urinalysis was positive for 2+ blood, and peritoneal fluid contained a total nucleated ce [....] » Read More

Speaker at Infectious Diseases Conference - Aaron Briggs
Poster Presentation (Virtual)
Aaron Briggs, University of California San Diego, United States

Background: The World Health Organization (WHO) estimated the global incidence of syphilis among adults to be approximately 7.1 million in 2020. The following year, the American Centers for Disease Control and Prevention (CDC) reported a 32% increase in the incidence of primary/s [....] » Read More

Speaker at Infectious Diseases Conference - Simona Di Cesare
Poster Presentation (Virtual)
Simona Di Cesare, U.O. Medicina Interna Ospedale Pierantoni, Italy

Background: Patients with acquired immunodeficiency syndrome HIV disease can present with a constellation of symptoms and syndromes. In this abstract we describe a rare case of human herpesvirus 8 (HHV-8) apparently unrelated and not multicentric Castleman disease (CD), as the pr [....] » Read More

Speaker at Infectious Diseases Conferences - Eduardo Ferracioli Oda
Poster Presentation (Virtual)
Eduardo Ferracioli Oda, University of Sao Paulo, Brazil

Purpose: To describe the pathogens detected in intraocular fluid of individuals with active uveitis using a low-volume direct multiplex PCR. Methods: Eighty-six individuals with active uveitis were included in this study between July, 21 and November, 23. All participants had [....] » Read More

Speaker at Infectious Diseases Conferences - Abhilasha
Poster Presentation (Virtual)
Abhilasha, Kanpur Institute of Technology, India

There are currently an estimated 39.0 million people living with HIV around the world. Sexually transmitted infections, also known as STDs, continue to be a major public health challenge in developing countries. The prevalence of STIs, including bacterial (Chlamydia trachomatis, [....] » Read More

Speaker at Infectious Diseases Conference - N Sowmiya Devi
Poster Presentation (Virtual)
N Sowmiya Devi, Madras Medical College, India

A 53 year old female presented with reddish raised lesion over left anterior shin for 3 years which eventually ruptured into ulcer, lesion gradually increased in size, purulent discharge from ulcer. Patient had similar compliants  2 years back wound debridement was done outs [....] » Read More

Speaker at Infection Conference - Divya S
Poster Presentation (Virtual)
Divya S, Madras Medical College, India

A 50 year old male admitted with complaints of left sided chest pain for 15 days, dull aching type, history of shortness of breath on exertion for 15 days, no history of previous similar complaints and no previous history of Pulmonary Tuberculosis, no other associated comorbiditi [....] » Read More

Speaker at Infection Conferences - M Kingston
Poster Presentation (Virtual)
M Kingston, Madras Medical College, India

A 35 year old male admitted with complaints of cough with expectoration for 3 weeks, which is mucoid in consistency, sometimes blood tinged, history of evening rise of temperature for last 14 days, history of loss of weight and loss of appetite present, no history of pervious sim [....] » Read More

Speaker at Infection Conferences - M Kingston
Poster Presentation (Virtual)
M Kingston, Madras Medical College, India

The patient, a 37 year old non-smoker and occasional alcoholic, presented with a three-week history of cough, blood-tinged expectoration, evening fevers, weight loss, and loss of appetite. There was no previous history of Pulmonary Tuberculosis. Notably, the patient had irregular [....] » Read More

Speaker at Infectious Diseases Conference - Yusuf Haz Condeng
Poster Presentation (Virtual)
Yusuf Haz Condeng, Hasanuddin University, Indonesia

Introduction and objectives: COVID-19 induces a state of hypercoagulability, with advanced age identified as a significant risk factor for infection. The interplay between hypercoagulability and advanced age has far-reaching implications for the clinical course of COVID-19. This [....] » Read More

Speaker at Infection Conference - Clare Symonds
Poster Presentation (Virtual)
Clare Symonds, Meningitis Research Foundation, United Kingdom

UNICEF and MRF have conducted primary research on communications about meningitis in high-burden countries in the meningitis belt; a string of 26 countries that experience the highest burden of disease. The research was designed to assess approaches to, and the need for, communic [....] » Read More

Speaker at Infectious Diseases Conference - Irina Metonidze
Poster Presentation (Virtual)
Irina Metonidze, University of Georgia, Georgia

Background: Several studies suggest an association between serum 25-hydroxyvitamin D (25OHD) and the outcomes of Corona-Virus-2 (SARS-CoV-2) infection, in particular COVID-19 Pandemic related severity and mortality. The aim of the present was to investigate whether vitamin D stat [....] » Read More

Speaker at Infectious Diseases Conferences - David Stiles
Poster Presentation (Virtual)
David Stiles, Recursion Pharmaceuticals, United States

REC-3964 is an oral, novel, diazepinedione-class chemical entity identified from Recursion’s high-content phenotypic imaging platform. REC-3964 inhibits toxins associated with Clostridioides difficile infection (CDI). In a disease-relevant hamster model of acute CDI, REC [....] » Read More

Speaker at Infection Conferences - Suchit Chidurala
Poster Presentation (Virtual)
Suchit Chidurala, Joe R. and Teresa Lozano Long School of Medicine, United States

Infective endocarditis (IE) is a serious inflammation of the inner lining of the heart. It is caused by pathogens entering the bloodstream and infecting the endocardium. Early diagnosis of IE is essential to improve clinical outcomes and survival; however, due to the subtle sympt [....] » Read More

Watsapp